The Enterprise Value as of December 2025 (TTM) for Artelo Biosciences, Inc. (ARTLW) is 2.73M

According to Artelo Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.73M. This represents a change of -73.80% compared to the average of 10.41M of the last 4 quarters.

Artelo Biosciences, Inc. (ARTLW) Historical Enterprise Value (quarterly & annually)

How has ARTLW Enterprise Value performed in the past?

The mean historical Enterprise Value of Artelo Biosciences, Inc. over the last ten years is 7.22M. The current 2.73M Enterprise Value has changed 3.68% with respect to the historical average. Over the past ten years (40 quarters), ARTLW's Enterprise Value was at its highest in in the August 2018 quarter at 122.04M. The Enterprise Value was at its lowest in in the November 2020 quarter at -1116676.00.

Artelo Biosciences, Inc. (ARTLW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Artelo Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Artelo Biosciences, Inc. (ARTLW) Average Enterprise Value

How has ARTLW Enterprise Value performed in the past?

The current Enterprise Value of Artelo Biosciences, Inc. (ARTLW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Artelo Biosciences, Inc. (ARTLW) Enterprise Value vs. Peers

How is ARTLW’s Enterprise Value compared to its peers?

Artelo Biosciences, Inc.’s Enterprise Value is less than Eyenovia, Inc. (38.86M), less than Arrowhead Pharmaceuticals, Inc. (10.27B), less than Krystal Biotech, Inc. (6.71B), less than BioNTech SE (9.37B), less than Moderna, Inc. (11.07B), less than Adynxx, Inc. (0), greater than AVAX Technologies, Inc. (-8870686.00), greater than BioCardia, Inc. (-5896313.00), less than Adial Pharmaceuticals, Inc. WT EXP 073123 (3.88M), greater than Ascletis Pharma Inc. (2.50M), less than Ampio Pharmaceuticals, Inc. (11.07B), greater than NexImmune, Inc. (-3809096.00), greater than CymaBay Therapeutics, Inc. (-3133504.00), less than Galera Therapeutics, Inc. (3.64B), less than Exelixis, Inc. (147.63M), less than null (10.76B),

Build a custom stock screener for Artelo Biosciences, Inc. (ARTLW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Artelo Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Artelo Biosciences, Inc. (ARTLW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Artelo Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.